Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia

Recruiting N/A Interventional Study
Primary Ciliary Dyskinesia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 – 50
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
29 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Primary ciliary dyskinesia (PCD) is a rare disease, caused by impairment of the motile cilia. Patients present with chronic upper and lower respiratory tract infections. The therapy is mainly supportive and based on that of cystic fibrosis. Chest physiotherapy is one of the cornerstones of the therapy, however the influence of chest physiotherapy on lung function (short term and long term) is not …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Primary ciliary dyskinesia * able to perform spirometry and MBW (\>6 years) Exclusion Criteria: * acute exacerbation
Contacts

Mieke Boon, MD

+3216342589

mieke.boon@uzleuven.be

CONTACT